Key points are not available for this paper at this time.
Globa D proved the best drug candidate against Neisseria gonorrhoeae by inhibiting PorB Porin protein chain A. Further in vitro and in vivo studies are recommended to validate these findings and explore clinical applications.
Hussain et al. (Mon,) studied this question.